Rebate Rule Will Increase Premiums for Medicare Part D Beneficiaries, Do Nothing to Lower Drug Prices and Pad Drug Companies’ Bottom Line For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Friday after the Trump Administration announced it will publish a final rule […]
Pfizer Releases Positive Preliminary Data on Vaccine, Must Commit to Affordable Pricing For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Monday reacting to preliminary data released by Pfizer Inc. on the efficacy of the company’s COVID-19 vaccine. “Any COVID-19 treatments and vaccines […]
Surrogates for the 2020 Candidates Should Demonstrate Commitment To Lowering Rx Prices and Reject Big Pharma Blame Game in Town Hall For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Tuesday ahead of a drug pricing town hall with representatives from both the […]
Brand Name Drug Company Shirks Requirement to Provide Affordable Medications to Covered Providers as Industry Complains About High Discounts Partially Driven by Its Own Price Hikes For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Thursday criticizing AstraZeneca for becoming the second Big Pharma […]
House Committee on Oversight and Reform to Question Big Pharma Executives During Two-Day Hearing on “Unsustainable Drug Prices” For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Wednesday ahead of two days of testimony from Big Pharma executives before the U.S. House Committee […]
Report Finds Market-Based Solutions to Boost Biosimilar Competition and Hold Drug Companies Accountable Would Lower Prices And Increase Innovation For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Tuesday reacting to a new study from Avik Roy and Gregg Girvan of the Foundation […]
Tweet Misstates Impact of Misguided Rebate Rule That Would Do Nothing to Lower Drug Prices, While Increasing Medicare Premiums For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Sunday in response to tweet chain from the president announcing he signed an executive order tying drug prices […]
U.S. House Oversight Committee Subpoena of AbbVie Related to Pricing of Blockbuster Cancer, Immunosuppressant Drugs Will Help Hold Industry Accountable For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday in response to news that the U.S. House Oversight Committee will subpoena Big […]
Tracking Data Finds Drug Companies Increased Prices On at Least 67 Brand Name Drugs This Summer Despite Economic Crisis and Rising Concern With Rx Affordability For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday on updated data showing Big Pharma continued hiking […]
White House Should Reject Pharma-Backed Policies That Would Hand Drug Companies a Windfall on the Backs of American Taxpayers For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Wednesday in response to two alternative drug pricing proposals to Medicare Parts B and D […]